The RTS,S/AS01 Malaria Vaccine Implementation Programme in Ghana, Kenya and Malawi

Edited by:

Arantxa Roca-Feltrer, PhD, PATH, Mozambique
Busiku Hamainza, PhD, Ministry of Health, Zambia

Submission Status: Open

Malaria Journal is announcing this invite only collection on the RTS,S/AS01 Malaria Vaccine Implementation Programme in Ghana, Kenya and Malawi. For more information refer to About the collection below.

Image credit: WHO/Fanjan Combrink

New Content Item This Collection supports and amplifies research related to SDG 3: Good Health and Well-Being.

Submit to Collection

Meet the Guest Editors

Back to top

Arantxa Roca-Feltrer, PhD, PATH, Mozambique

Dr. Arantxa Roca-Feltrer is a PhD malaria epidemiologist trained at the London School of Hygiene and Tropical Medicine (LSHTM) with over 20 years of experience in both malaria control and malaria elimination countries from the African and Asian regions. From 2012 to 2016 Doctor Roca-Feltrer supported malaria elimination efforts in the Greater Mekong Subregion (GMS). As part of her current position as Regional Malaria Director at PATH, she contributes to supporting global strategic policies, approaches and priorities for Surveillance as well as M&E strategies within the malaria control to elimination spectrum to the regions and country offices. She is currently based in Mozambique since 2018 where she leads surveillance strengthening initiatives in the region.

Busiku Hamainza, PhD, Ministry of Health, Zambia

Dr. Busiku Hamainza is a seasoned public health expert with over two decades of experience, specializing in malaria epidemiology and global health management. With a PhD in Tropical Medicine from the Liverpool School of Tropical Medicine, BH has led national efforts in Zambia to combat malaria, HIV, and TB through various leadership roles, including Acting Director at the National Malaria Elimination Centre and current Grants Coordinator at the Ministry of Health. BH is skilled in program management, disease surveillance, capacity building and health systems strengthening, and is committed to advancing public health through evidence-based research and policy.

About the Collection

Malaria Journal invites colleagues to contribute to a collection of scientific literature to showcase the findings and lessons learned from the WHO-coordinated Malaria Vaccine Implementation Programme (MVIP), through which the RTS,S/AS01 (RTS,S) malaria vaccine was introduced in pilot, subnational implementations and the safety, feasibility and impact was measured. WHO provided scientific and technical leadership for the MVIP and implemented the program in partnership with the Ministries of Health of Ghana, Kenya and Malawi, PATH, GSK and UNICEF.

In October 2021, informed by findings from the MVIP, WHO recommended RTS,S vaccine to prevent P. falciparum malaria in children. A second malaria vaccine, R21/Matrix-M, was recommended by WHO in October 2023.

WHO recommends the use of malaria vaccines, RTS,S and R21, for the prevention of P. falciparum malaria in children living in malaria endemic areas, prioritizing areas of moderate and high transmission.

Image credit: WHO/Fanjan Combrink

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of research articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “The RTS,S/AS01 Malaria Vaccine Implementation Programme in Ghana, Kenya and Malawi" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.